| George B Reservitz, MD | |
|
300 Mt. Auburn Street, Suite 519, Suite 519, Cambridge, MA 02138-5600 | |
| (617) 547-4400 | |
| (617) 576-1076 |
| Full Name | George B Reservitz |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 300 Mt. Auburn Street, Suite 519, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225037518 | NPI | - | NPPES |
| 6172219 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 27845 (Massachusetts) | Primary |
| Entity Name | Massachusetts Institute Of Technology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346308723 PECOS PAC ID: 5597658666 Enrollment ID: O20040203000789 |
News Archive
The kids may be sleeping soundly this season with "visions of sugar plums in their heads," but almost half of the nation's moms and dads (44%) say they are worried about being able to afford the holidays this year, with one in six Americans (17%) expecting to lose sleep due to holiday-induced stress.
Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."
Multiple sclerosis, an autoimmune disorder, is known to be driven by "helper" T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study from Boston Children's Hospital pinpoints the specific subgroup of helper T cells that cause MS, as well as a protein on their surface, called CXCR6, that marks them.
A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.
Keryx Biopharmaceuticals, Inc. today announced that a manuscript entitled "Perifosine Plus Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Bortezomib: Results of a Multicenter Phase l/2 Trial" reporting Phase 1 / 2 combination activity of KRX-0401 (perifosine) in the treatment of advanced multiple myeloma (MM) patients, was selected for publication in the October 11, 2011 online edition of the Journal of Clinical Oncology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George B Reservitz, MD 300 Mt. Auburn Street, Suite 519, Suite 519, Cambridge, MA 02138-5600 Ph: (617) 547-4400 | George B Reservitz, MD 300 Mt. Auburn Street, Suite 519, Suite 519, Cambridge, MA 02138-5600 Ph: (617) 547-4400 |
News Archive
The kids may be sleeping soundly this season with "visions of sugar plums in their heads," but almost half of the nation's moms and dads (44%) say they are worried about being able to afford the holidays this year, with one in six Americans (17%) expecting to lose sleep due to holiday-induced stress.
Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."
Multiple sclerosis, an autoimmune disorder, is known to be driven by "helper" T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord. A new study from Boston Children's Hospital pinpoints the specific subgroup of helper T cells that cause MS, as well as a protein on their surface, called CXCR6, that marks them.
A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.
Keryx Biopharmaceuticals, Inc. today announced that a manuscript entitled "Perifosine Plus Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Bortezomib: Results of a Multicenter Phase l/2 Trial" reporting Phase 1 / 2 combination activity of KRX-0401 (perifosine) in the treatment of advanced multiple myeloma (MM) patients, was selected for publication in the October 11, 2011 online edition of the Journal of Clinical Oncology.
› Verified 5 days ago
Roderick H Crocker Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Ste 519, Cambridge, MA 02138 Phone: 617-547-4400 Fax: 617-576-1076 | |
Dr. Maria Alexandra Ordonez, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2555 | |
Louis S Liou, M.D., PH.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-3590 | |
James C Ku, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Suite 519, Cambridge, MA 02138 Phone: 617-547-4400 Fax: 617-576-1076 | |
Paul D Lafontaine, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Ste 519, Cambridge, MA 02138 Phone: 617-547-4400 Fax: 617-576-1076 |